Agilent Technologies, Inc. (A), headquartered in Santa Clara, California, provides application focused solutions to the life ...
Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Puneet Souda from Leerink Partners maintained a Buy rating on the stock and has ...
Agilent Technologies A reported fourth-quarter fiscal 2024 earnings of $1.46 per share, which beat the Zacks Consensus ...
I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...
Throughout the last three months, 4 analysts have evaluated Agilent Technologies A +0.10% Get Free Report , offering a ...
In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating 5.96% over the last five trades and 3.30% over the past 30 trades. This represents a notable shift ...
Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rachel Vatnsdal from J.P. Morgan maintained a Buy rating on the stock and has a $160 ...
Agilent Technologies posted lower profit in the fourth quarter despite a slight rise in its revenue. The Santa Clara, Calif.-based laboratory-supply and services company on Monday reported a profit of ...
SANTA CLARA, Calif. — SANTA CLARA, Calif. — Agilent Technologies Inc. (A) on Monday reported fiscal fourth-quarter earnings of $351 million. The Santa Clara, California-based company said it had ...
Agilent Technologies Trading Up 1.3 % Shares of Agilent Technologies stock opened at $133.84 on Friday. The business has a 50 day moving average price of $137.90 and a 200 day moving average price ...
The ZORBAX RRHD 300-HILIC columns for glycopeptide analysis feature 1.8 µm particles and a 300Å pore size. These enable to resolve peptide glycoforms. The ZORBAX RRHD 300-HILIC columns are part ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...